Stendra is a Oral Tablet in the Human Prescription Drug category. It is labeled and distributed by Mist Pharmaceuticals, Llc. The primary component is Avanafil.
Product ID | 76299-320_3e7ad8d2-412c-4253-81f1-cd542ebab45b |
NDC | 76299-320 |
Product Type | Human Prescription Drug |
Proprietary Name | Stendra |
Generic Name | Avanafil |
Dosage Form | Tablet |
Route of Administration | ORAL |
Marketing Start Date | 2013-12-27 |
Marketing Category | NDA / NDA |
Application Number | NDA202276 |
Labeler Name | Mist Pharmaceuticals, LLC |
Substance Name | AVANAFIL |
Active Ingredient Strength | 50 mg/1 |
Pharm Classes | Phosphodiesterase 5 Inhibitor [EPC],Phosphodiesterase 5 Inhibitors [MoA] |
NDC Exclude Flag | N |
Listing Certified Through | 2019-12-31 |
Marketing Start Date | 2013-12-27 |
NDC Exclude Flag | N |
Sample Package? | N |
Marketing Category | NDA |
Application Number | NDA202276 |
Product Type | HUMAN PRESCRIPTION DRUG |
Billing Unit | EA |
Marketing Start Date | 2013-12-27 |
Inactivation Date | 2020-01-31 |
Marketing Category | NDA |
Application Number | NDA202276 |
Product Type | HUMAN PRESCRIPTION DRUG |
Marketing Start Date | 2013-12-27 |
Inactivation Date | 2020-01-31 |
Ingredient | Strength |
---|---|
AVANAFIL | 50 mg/1 |
SPL SET ID: | a8726f90-9329-46ca-9379-2b50c78fe0e2 |
Manufacturer | |
UNII | |
RxNorm Concept Unique ID - RxCUI |
NDC | Brand Name | Generic Name |
---|---|---|
62541-501 | STENDRA | Avanafil |
62541-502 | STENDRA | Avanafil |
62541-503 | STENDRA | Avanafil |
72384-751 | Stendra | avanafil |
72384-752 | Stendra | avanafil |
72384-753 | Stendra | avanafil |
76299-320 | Stendra | avanafil |
76299-321 | Stendra | avanafil |
76299-322 | Stendra | avanafil |
Mark Image Registration | Serial | Company Trademark Application Date |
---|---|
STENDRA 85565411 4526269 Live/Registered |
METUCHEN PHARMACEUTICALS, LLC 2012-03-09 |